Methadone for Emergence Delirium in Children Undergoing Outpatient Strabismus Surgery

Strabismus surgery for children is a very common procedure, with a high incidence of emergence delirium in the recovery room. Pain is often implicated in delirium. The primary aim of this study is to determine whether a single, intraoperative dose of methadone for outpatient ambulatory pediatric strabismus surgery reduces postoperative delirium.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Emergence Delirium Confusion Cranial Nerve Diseases Delirium Eye Diseases Mental Disorders Nervous System Diseases Neurobehavioral Manifestations Neurocognitive Disorders Neurologic Manifestations Ocular Motility Disorders Pathologic Processes Pathological Conditions, Signs and Symptoms Postoperative Complications Signs and Symptoms Strabismus

Age range

0 year–18 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Ochsner Main Campus

Jefferson, Louisiana, 70121, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

ASA I/II children undergoing outpatient strabismus surgery

Exclusion criteria

anything not meeting the above

Treatment and study plan

Methadone

Drug

see desc above

Primary outcomes

Pediatric Anesthesia Emergence Delirium scale scores

Time frame: measured every 10 minutes in the recovery room, until patient is discharged, up to 6 hours.

A low total score would indicate less emergence delirium

Secondary outcomes

wong-baker or numeric pain scores, depending on age

Time frame: measured every 10 minutes in the recovery room, until patient is discharged, up to 6 hours.

A low total score would indicate less pain
discharge time

Time frame: 24 hours

time the patient is actually discharged from recovery room

Sponsors and collaborators

Lead sponsor

Ochsner Health System

Other

Registry information

Important dates

Study start: 2019
Primary completion: 2020
Study completion: 2020
First posted: Dec 19, 2018
Registry last updated: Jul 19, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed